WEBSITECHANGES

Website Changes

---

12/28/2010

The paradoxical effect of bevacizumab in the therapy of malignant gliomas

---

12/23/2010

Electrical Device for Cancer Treatment Polarizes Audiences

---

12/23/2010

ImmunoCellular Therapeutics (IMUC): At the Forefront of Brain Tumor Treatment

---

12/23/2010

Peregrine Completes Treatment of Last Patient in Phase II Cotara(R) Brain Cancer Trial

---

12/22/2010

Updated survivor story for Rose - a 4 year gbm survivor - recently with a clean scan!

---

12/17/2010

virtualtrials.com is back up!

---

12/17/2010

Insight offers new angle of attack on variety of brain tumors

---

12/16/2010

IBTA December 2010 E-News

---

12/15/2010

Florida Brain Tumor Association Brain Tumor Conference

---

12/14/2010

Induction of CD8+ T-Cell Responses Against Novel Glioma–Associated Antigen Peptides and Clinical Activity by Vaccinations With a-Type 1 Polarized Dendritic Cells and Polyinosinic-Polycytidylic Acid Stabilized by Lysine and Carboxymethylcellulose in Patients With Recurrent Malignant Glioma [Editor`s Note: This project was funded by the Musella Foundation]

---

12/07/2010

Phase II Study of Bevacizumab Plus Temozolomide During and After Radiation Therapy for Patients With Newly Diagnosed Glioblastoma Multiforme

---

12/04/2010

New Drugs Target Recurrent Meningioma

---

12/02/2010

Device for Glioblastoma May Offer Advantage Over Chemo

---

12/02/2010

Baptist Hospital Patients To Receive First-Of-Kind Tumor Treatment [Low Grade Glioma Vaccine!]

---

12/01/2010

Bevacizumab Combinations Effective in Phase II Glioblastoma Trials

---

11/30/2010

Fuel Lines of Tumors Are New Target

---

11/28/2010

Prothrombotic state in glioblastoma multiforme: an evaluation of the procoagulant activity of circulating microparticles

---

11/22/2010

Paclitaxel Poliglumex (OPAXIO®) Combined with Temozolomide and Radiotherapy Demonstrates High Response Rates with Encouraging Progression Free Survival in Malignant Brain Cancer

---

11/21/2010

Brain Tumors Grow Their Own Blood Supply

---

11/20/2010

Professor Zvi Ram Presents Phase III Recurrent Glioblastoma Survival and Quality of Life Data from the First Pivotal Study of the NovoTTF-100A at the 15th Annual Society for Neuro-Oncology (SNO) Scientific Meeting

---

11/20/2010

Celldex Therapeutics Reports Positive Results from Rindopepimut Phase 2 Brain Cancer Study at SNO 2010

---

11/19/2010

The Ketogenic Diet Reverses Gene Expression Patterns and Reduces Reactive Oxygen Species Levels When Used as an Adjuvant Therapy for Glioma

---

11/15/2010

Cancer treatment shows promise

---

11/13/2010

Biocomputing: Numerical simulation of glioblastoma growth and comparison with conventional irradiation margins.

---

11/10/2010

Benefits of interferon-ß and temozolomide combination therapy for newly diagnosed primary glioblastoma with the unmethylated MGMT promoter: a multicenter study.

---